Northern District of California Court Excludes Expert’s Apportionment Methodology Due to Double or Triple Counting Revenue Attributable to Certain Features of the Accused Products

Aug 24, 2016

Reading Time : 1 min

Finjan argued that its expert’s calculations were not unreliable because she calculated the damages on a per-patent basis so that, if any of the patents were invalidated, the jury could still calculate damages specific to each patent. Moreover, Finjan argued that the expert applied a royalty rate to her royalty base to calculate an overall reasonable royalty well below the total revenues for the products. The court, however, was not persuaded. The court stated that “[w]hile [the expert’s] ultimate reasonable royalty calculation is less than the total revenues . . . [the expert’s] method of counting the revenue attributable to certain features multiple times, when those features are covered by multiple patents, is not a reasonable method of counting the value added by the patented features.” The court provided an example that if only 6/12 total features of a particular product are covered by any of the accused patents, and it is assumed that each feature has equal value, then the total value attributed to the patented features cannot exceed 50% of the total product value. But, in Finjan’s case, the expert’s calculations assumed that the combined value attributed to the patented features would exceed the total product value, which would mislead the jury.

The court concluded by granting Finjan leave to amend the expert report and noted that this flaw could be amended, for instance, by creating a flexible damage calculation that reflects the total possible royalty attributable to each patent, but then accounts for overlap in the patents’ covered features to prevent double counting.

Finjan, Inc. v. Sophos, Inc., 3-14-cv-01197 (N.D. Cal. August 15, 2016).

Share This Insight

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.